PPARD and cancer: By improving the absorption of curcumin and cellular uptake of curcumin, curcumin derivatives may be more potent in suppressing the FABP5/PPARβ/δ pathway, and enhance the efficacy of RA by reducing the dosage to be used in vivo, in order to better tolerate its use in cancer patients.